Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
Provided By GlobeNewswire
Last update: Jan 10, 2025
LOUISVILLE, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its preliminary financial results for the fourth quarter and year ended December 31, 2024 (fiscal 2024). The financial results included in this release pertaining to the fourth quarter and fiscal 2024 are preliminary, unaudited, and subject to final review and adjustment.
Read more at globenewswire.com0.713
-0.08 (-10.09%)
Find more stocks in the Stock Screener
BDSX Latest News and Analysis
15 hours ago - ChartmillGet insights into the top gainers and losers of Monday's after-hours session.The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
